Lv7
4620 积分 2022-08-13 加入
Excellent Response to 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in a Patient With Progressive Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation After 177Lu-PSMA Therapy
1个月前
已完结
177Lu-PSMA and 177Lu-DOTATATE Therapy in a Patient With Metastatic Castration-Resistant Prostate Cancer and Neuroendocrine Differentiation
1个月前
已完结
Orbital Metastasis from Prostatic Carcinoma
1个月前
已关闭
Prostate Carcinoma And The Lambert-Eaton Myasthenic Syndrome
1个月前
已完结
Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy
1个月前
已完结
Diagnosing and Treating Small-Cell Carcinomas of Prostatic Origin
1个月前
已完结
Clinical evidence of neuroendocrine differentiation in a patient with prostate cancer and bone marrow micrometastases
1个月前
已完结
Prostatic small‐cell neuroendocrine carcinoma with disease progression monitored by measurement of serum progastrin‐releasing peptide
1个月前
已完结
Cushing’s Syndrome in Prostate Cancer
1个月前
已关闭
Pediatric Articles
1个月前
已关闭
皖公网安备34019202002308
